HRC Ledger
Opportunity

Operational Medicine Test and Evaluation Cell Salvage Supplemental - (AFMEDCOM)

Response due

November 16, 2026

Agency
FA8003 771 Enterprise Sourcing Sq
Estimated value
Not stated
This supplemental market research will help identify solutions that can safely bridge the time to surgery in austere environments. The purpose of this RFI is to request information to determine your company’s services and capabilities to meet our government requirement for a device to perform cell salvage, blood conditioning, and autonomous return with flow rate control of blood delivery to include prototypes. The information gathered from all companies that answer the RFI will be analyzed against the requirements to effectively identify capabilities that are available in the marketplace/industry. Both large business concerns and all categories of small business are encouraged to respond to this request. The following North American Industry Classification System (NAICS) code(s) may possibly be used for this requirement: 339112 – Surgical and Medical Instrument Manufacturing. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract.

Key dates

Posted
October 16, 2026
Response due
November 16, 2026

Organization

FA8003 771 Enterprise Sourcing Sq

Buying history

  • Records5 total
  • Opportunities / awards4 / 1
  • Value range$1,465,813 – $1,465,813
  • ActiveSeptember 28, 2026 – October 17, 2026

What they buy

  • Clinical (5)

Set-asides used

  • Small Business Set Aside - Total (3)

Who holds their work today

  1. DISTINCTIVE HEALTH SPECTRUM CARE JV LLC1 win · $1,465,813 · last September 30, 2022

Also open from this buyer

View source document →

Source link on sam.gov.

Source record

Buyer type
Federal
Jurisdiction
Federal (US)
Category
Clinical
Set-aside
Not stated
NAICS
339112
PSC
Not stated